Pharmaceutically acceptable salt of a hexahydrooxazinopterine compound
PK141255AUndetermined Publication Date: 2011-09-24TAKEDA PHARMA CO LTD
0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- TAKEDA PHARMA CO LTD
- Publication Date
- 2011-09-24
Abstract
The present invention provides a pharmaceutically acceptable salt of an mTOR inhibitor of the formula wherein the variables are as defined herein. Also provided is a pharmaceutical composition and article of manufacture comprising such salt of the compound; method of making the salt of the compound, and intermediate thereof.
Need to check novelty before this filing date? Find Prior Art